These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11600526)

  • 1. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion.
    Arlt W; Callies F; Koehler I; van Vlijmen JC; Fassnacht M; Strasburger CJ; Seibel MJ; Huebler D; Ernst M; Oettel M; Reincke M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4686-92. PubMed ID: 11600526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    Arlt W; Callies F; van Vlijmen JC; Koehler I; Reincke M; Bidlingmaier M; Huebler D; Oettel M; Ernst M; Schulte HM; Allolio B
    N Engl J Med; 1999 Sep; 341(14):1013-20. PubMed ID: 10502590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity.
    Callies F; Fassnacht M; van Vlijmen JC; Koehler I; Huebler D; Seibel MJ; Arlt W; Allolio B
    J Clin Endocrinol Metab; 2001 May; 86(5):1968-72. PubMed ID: 11344193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ; Nolan JJ; Nelson JC; Yen SS
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men.
    Kahn AJ; Halloran B; Wolkowitz O; Brizendine L
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1544-9. PubMed ID: 11932279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G; Burman P; Wirén L; Engström BE; Nilsson AG; Ottosson M; Jonsson B; Bengtsson BA; Karlsson FA
    J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D; Laughlin GA; Kritz-Silverstein D; Barrett-Connor E
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A; Kaufman JM; Giagulli VA
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
    Wolf OT; Neumann O; Hellhammer DH; Geiben AC; Strasburger CJ; Dressendörfer RA; Pirke KM; Kirschbaum C
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2363-7. PubMed ID: 9215320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHEA replacement in women with adrenal insufficiency--pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition.
    Arlt W; Callies F; Allolio B
    Endocr Res; 2000 Nov; 26(4):505-11. PubMed ID: 11196420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial.
    Rice SP; Agarwal N; Bolusani H; Newcombe R; Scanlon MF; Ludgate M; Rees DA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1966-72. PubMed ID: 19318448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ; Gravholt CH; Fisker S; Svenstrup B; Bennett P; Veldhuis J; Andersen M; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial.
    Løvås K; Gebre-Medhin G; Trovik TS; Fougner KJ; Uhlving S; Nedrebø BG; Myking OL; Kämpe O; Husebye ES
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1112-8. PubMed ID: 12629093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
    Binder G; Weber S; Ehrismann M; Zaiser N; Meisner C; Ranke MB; Maier L; Wudy SA; Hartmann MF; Heinrich U; Bettendorf M; Doerr HG; Pfaeffle RW; Keller E;
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1182-90. PubMed ID: 19126625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3773-9. PubMed ID: 16849414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone replacement in aging humans.
    Flynn MA; Weaver-Osterholtz D; Sharpe-Timms KL; Allen S; Krause G
    J Clin Endocrinol Metab; 1999 May; 84(5):1527-33. PubMed ID: 10323374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life.
    Barnhart KT; Freeman E; Grisso JA; Rader DJ; Sammel M; Kapoor S; Nestler JE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3896-902. PubMed ID: 10566625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.